Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection

Cytokine-induced killer (CIK) cell therapy has recently been used as an adjuvant setting following resection of hepatocellular carcinoma (HCC), while its benefit remains unclear. This study aimed to evaluate the efficacy of adjuvant CIK application in solitary HCC patients undergoing curative resect...

Full description

Saved in:
Bibliographic Details
Published in:Medicine (Baltimore)
Main Authors: Chen, Jian-Lin, Lao, Xiang-Ming, Lin, Xiao-Jun, Xu, Li, Cui, Bo-Kang, Wang, Jun, Lin, Guo-He, Shuang, Ze-Yu, Mao, Yi-Ze, Huang, Xin, Yun, Jing-Ping, Jin, Jie-Tian, Li, Sheng-Ping
Format: Artigo
Language:Inglês
Published: Wolters Kluwer Health 2016
Subjects:
7300
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4748913/
https://ncbi.nlm.nih.gov/pubmed/26844496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000002665
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items